Reduced Intensity Bone Marrow Transplantation with Post-Transplant Cyclophosphamide for Pediatric Inherited Immune Deficiencies and Bone Marrow Failure Syndromes

PURPOSE: Allogeneic bone marrow transplantation (alloBMT) is the only cure for many primary immune deficiency disorders (PIDD), primary immune regulatory disorders (PIRD), and inherited bone marrow failure syndromes (IBMFS). METHODS: We report the results of 25 patients who underwent alloBMT using r...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Clin Immunol
Päätekijät: Klein, Orly R., Bapty, Samantha, Lederman, Howard M., Younger, M. Elizabeth M., Zambidis, Elias T., Jones, Richard J., Cooke, Kenneth R., Symons, Heather J.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Springer US 2020
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7647188/
https://ncbi.nlm.nih.gov/pubmed/33159275
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10875-020-00898-0
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia